Cargando…
Identification of Neutrophil Activation Markers as Novel Surrogate Markers of CF Lung Disease
BACKGROUND AND AIMS: Cystic Fibrosis (CF) lung disease is characterized by progressively declining lung function and represents a major factor contributing to the high morbidity and mortality associated with CF. However, apart from spirometry, respiratory disease surrogate markers reliably indicatin...
Autores principales: | Rath, Timo, Zwaschka, Lisa, Hage, Lisa, Kügler, Marion, Menendez, Katrin, Naehrlich, Lutz, Schulz, Richard, Roderfeld, Martin, Roeb, Elke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278831/ https://www.ncbi.nlm.nih.gov/pubmed/25545245 http://dx.doi.org/10.1371/journal.pone.0115847 |
Ejemplares similares
-
Serum Proteome Profiling Identifies Novel and Powerful Markers of Cystic Fibrosis Liver Disease
por: Rath, Timo, et al.
Publicado: (2013) -
Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort study
por: Klotter, Victoria, et al.
Publicado: (2017) -
Circulating Adipokines and Hepatokines Serve as Diagnostic Markers during Obesity Therapy
por: Schmid, Andreas, et al.
Publicado: (2022) -
Circulating cf-miRNA as a more appropriate surrogate liquid biopsy marker than cfDNA for ovarian cancer
por: Gahlawat, Aoife Ward, et al.
Publicado: (2023) -
Cathepsin L and B as Potential Markers for Liver Fibrosis: Insights From Patients and Experimental Models
por: Manchanda, Mansi, et al.
Publicado: (2017)